NuGen Medical Devices Inc. Announces CFO Transition

Rhea-AI Summary

NuGen Medical Devices (TSXV: NGMDF) announced a change in senior finance leadership effective January 31, 2026. Veronique Laberge resigned as Chief Financial Officer and Corporate Secretary and Ajay Mishra was appointed to both roles. The company said Mr. Mishra will assume responsibility for financial reporting and related functions.

Positive

• Immediate appointment of a successor to the CFO role
• Continuity of financial reporting responsibility from January 31, 2026
• Company gratitude signals an orderly transition

Negative

• CFO resignation may create short-term execution or oversight risk
• Potential investor uncertainty until new CFO's track record is public

Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, announces that Veronique Laberge has resigned from her position as Chief Financial Officer and Corporate Secretary. Her resignation is effective January 31, 2026.

The Company has appointed Mr. Ajay Mishra as Chief Financial Officer and Corporate Secretary, effective January 31, 2026. Mr. Mishra will assume responsibility for the Company's financial reporting and related functions.

NuGen thanks Ms. Laberge for her contributions during her tenure with the Company.

About NuGen Medical Devices

NuGen develops next-generation needle-free devices for subcutaneous drug delivery. Its flagship InsuJet™ system is approved in 42 countries and is designed to improve the lives of millions of people with diabetes worldwide.

Websites: insujet.com | insujet.fr | nugenmd.com

LinkedIn: https://www.linkedin.com/company/nugen-medical-devices

Investor Relations: IR@nugenmd.com

For further information, please contact:
Liang Lin, Chief Executive Officer
+ 1-833-867-5557
ir@nugenmd.com

Notice Regarding Forward-Looking Information:

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282253

FAQ

Who is the new CFO of NuGen Medical Devices (NGMDF) and when does he start?

Ajay Mishra is the new CFO and Corporate Secretary, starting January 31, 2026. According to the company, Mr. Mishra will assume responsibility for financial reporting and related functions immediately upon appointment.

Why did Veronique Laberge resign as CFO of NuGen (NGMDF)?

The company announced her resignation effective January 31, 2026 without citing reasons. According to the company, NuGen thanked Ms. Laberge for her contributions during her tenure, indicating an amicable departure.

Will the CFO change at NuGen (NGMDF) affect financial reporting timelines?

The company says Ajay Mishra will assume responsibility for financial reporting effective January 31, 2026, suggesting no planned disruption. According to the company, reporting and related functions transfer to Mr. Mishra immediately.

Does the NuGen (NGMDF) announcement indicate any other executive changes or restructuring?

No other executive changes were announced alongside the CFO transition on January 30, 2026. According to the company, the release only covers the resignation of Ms. Laberge and appointment of Mr. Mishra to CFO and Corporate Secretary.

How should investors interpret the CFO transition at NuGen Medical Devices (NGMDF)?

The appointment provides immediate leadership continuity for finance functions from January 31, 2026. According to the company, investors can expect Mr. Mishra to handle financial reporting and related responsibilities going forward.